Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session

Physicians, Payers & Patients: ensuring high-quality data driven decisions through effective communication

About This Webinar

When launching and commercialising a new drug or remedy for market, there is often a lack of sufficient evidence and strong statistical insight to support the planning and preparation process. Such poor practice often generates poor results, misguided insight and avoidable business errors across multiple stages of the launch process. 

As Statisticians, we work on the front lines of clinical data, using statistical analysis to find meaningful evidence and insight that can help make informed clinical and business decisions. However, even when delivering clinical study reports and submission documents, the resulting publications can often lack an in-depth statistical review.

In this webinar you will learn about how statistical evidence flows through organisations from its origin to physicians, payers, and patients. Discover which parts of the information flow can trigger lower quality, and how to influence these areas to ensure that the quality of evidence is retained up to the final external customer.

  • How statistical evidence flows through organisations from its origin to patients, physicians, and payers.
  • Which parts of the information flow can trigger lower quality, and how to influence these areas.
  • How to ensure that the quality of evidence from your clinical data is retained right up to the end buyer and patient adoption.
Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter
Executive VP of Launch and Development Data Sciences
Alexander drives all services around the non-regulatory work. He contributes his 20+ years of experience to ensure high quality data-driven decisions within sponsors and for patients, physicians, and payers.

Alexander worked in leading positions for sponsors over the first 2 decades of the century in various indications including immunology, virology, neuroscience, urology, respiratory, and psychiatry. He has expertise across all clinical phases. Since 2004, he has concentrated on successfully launching and commercializing new treatments.

Alexander holds a PhD in Biostatistics and is an active member of Statisticians in Pharmaceutical Industry (PSI) where he served on the board of directors, founded and chaired the Visualization Special Interest group, chaired the Benefit-Risk Special Interest group, and contributed to many conferences, webinars, and one-day-events.

In 2018, he launched The Effective Statistician podcast in association with PSI in which he shares his insights around leadership, innovation, knowledge, and excellence required for a successful career in the healthcare industry. Dozens of guests across the industry and beyond helped to create a wealth of content to serve the statistical community.
Attended (29)